First US Implant of Carmat's Total Artificial Heart Performed at Duke

French artificial heart maker Carmat recently reported the first U.S. implantation of its bioprosthetic artificial heart, Aeson, was performed at Duke University Hospital as part of an early feasibility study. The device is designed as a therapeutic alternative for people with end-stage biventricular heart failure.